The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Implantable Neurostimulation Devices Market Research Report 2024

Global Implantable Neurostimulation Devices Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1410483

No of Pages : 80

Ask Your Query

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

The global Implantable Neurostimulation Devices market was valued at US$ 6640 million in 2023 and is anticipated to reach US$ 14080 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent. 
In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulation Devices.

Report Scope

The Implantable Neurostimulation Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Implantable Neurostimulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Implantable Neurostimulation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Medtronic
  •  Boston Scientific
  •  St. Jude Medical (Abbott)
  •  LivaNova
  •  Nevro
  •  NeuroPace
  •  Beijing Pins
  •  Synapse Biomedical

By Type

  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Others

By Application

  • Pain Management
  • Parkinson's Disease
  • Urinary and Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Neurostimulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Implantable Neurostimulation Devices Market Overview
1.1 Product Overview and Scope of Implantable Neurostimulation Devices
1.2 Implantable Neurostimulation Devices Segment by Type
1.2.1 Global Implantable Neurostimulation Devices Market Value Comparison by Type (2024-2030)
1.2.2 Spinal Cord Stimulation (SCS)
1.2.3 Gastric Electric Stimulation (GES)
1.2.4 Deep Brain Stimulation (DBS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Vagus Nerve Stimulation (VNS)
1.2.7 Others
1.3 Implantable Neurostimulation Devices Segment by Application
1.3.1 Global Implantable Neurostimulation Devices Market Value by Application: (2024-2030)
1.3.2 Pain Management
1.3.3 Parkinson's Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Others
1.4 Global Implantable Neurostimulation Devices Market Size Estimates and Forecasts
1.4.1 Global Implantable Neurostimulation Devices Revenue 2019-2030
1.4.2 Global Implantable Neurostimulation Devices Sales 2019-2030
1.4.3 Global Implantable Neurostimulation Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Implantable Neurostimulation Devices Market Competition by Manufacturers
2.1 Global Implantable Neurostimulation Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Implantable Neurostimulation Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Implantable Neurostimulation Devices Average Price by Manufacturers (2019-2024)
2.4 Global Implantable Neurostimulation Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Implantable Neurostimulation Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Implantable Neurostimulation Devices, Product Type & Application
2.7 Implantable Neurostimulation Devices Market Competitive Situation and Trends
2.7.1 Implantable Neurostimulation Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Implantable Neurostimulation Devices Players Market Share by Revenue
2.7.3 Global Implantable Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Implantable Neurostimulation Devices Retrospective Market Scenario by Region
3.1 Global Implantable Neurostimulation Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Implantable Neurostimulation Devices Global Implantable Neurostimulation Devices Sales by Region: 2019-2030
3.2.1 Global Implantable Neurostimulation Devices Sales by Region: 2019-2024
3.2.2 Global Implantable Neurostimulation Devices Sales by Region: 2025-2030
3.3 Global Implantable Neurostimulation Devices Global Implantable Neurostimulation Devices Revenue by Region: 2019-2030
3.3.1 Global Implantable Neurostimulation Devices Revenue by Region: 2019-2024
3.3.2 Global Implantable Neurostimulation Devices Revenue by Region: 2025-2030
3.4 North America Implantable Neurostimulation Devices Market Facts & Figures by Country
3.4.1 North America Implantable Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Implantable Neurostimulation Devices Sales by Country (2019-2030)
3.4.3 North America Implantable Neurostimulation Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Implantable Neurostimulation Devices Market Facts & Figures by Country
3.5.1 Europe Implantable Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Implantable Neurostimulation Devices Sales by Country (2019-2030)
3.5.3 Europe Implantable Neurostimulation Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Neurostimulation Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Implantable Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Implantable Neurostimulation Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Implantable Neurostimulation Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Implantable Neurostimulation Devices Market Facts & Figures by Country
3.7.1 Latin America Implantable Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Implantable Neurostimulation Devices Sales by Country (2019-2030)
3.7.3 Latin America Implantable Neurostimulation Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Implantable Neurostimulation Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Implantable Neurostimulation Devices Sales by Type (2019-2030)
4.1.1 Global Implantable Neurostimulation Devices Sales by Type (2019-2024)
4.1.2 Global Implantable Neurostimulation Devices Sales by Type (2025-2030)
4.1.3 Global Implantable Neurostimulation Devices Sales Market Share by Type (2019-2030)
4.2 Global Implantable Neurostimulation Devices Revenue by Type (2019-2030)
4.2.1 Global Implantable Neurostimulation Devices Revenue by Type (2019-2024)
4.2.2 Global Implantable Neurostimulation Devices Revenue by Type (2025-2030)
4.2.3 Global Implantable Neurostimulation Devices Revenue Market Share by Type (2019-2030)
4.3 Global Implantable Neurostimulation Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Implantable Neurostimulation Devices Sales by Application (2019-2030)
5.1.1 Global Implantable Neurostimulation Devices Sales by Application (2019-2024)
5.1.2 Global Implantable Neurostimulation Devices Sales by Application (2025-2030)
5.1.3 Global Implantable Neurostimulation Devices Sales Market Share by Application (2019-2030)
5.2 Global Implantable Neurostimulation Devices Revenue by Application (2019-2030)
5.2.1 Global Implantable Neurostimulation Devices Revenue by Application (2019-2024)
5.2.2 Global Implantable Neurostimulation Devices Revenue by Application (2025-2030)
5.2.3 Global Implantable Neurostimulation Devices Revenue Market Share by Application (2019-2030)
5.3 Global Implantable Neurostimulation Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Implantable Neurostimulation Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Implantable Neurostimulation Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 St. Jude Medical (Abbott)
6.3.1 St. Jude Medical (Abbott) Corporation Information
6.3.2 St. Jude Medical (Abbott) Description and Business Overview
6.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Portfolio
6.3.5 St. Jude Medical (Abbott) Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Corporation Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LivaNova Implantable Neurostimulation Devices Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Nevro
6.5.1 Nevro Corporation Information
6.5.2 Nevro Description and Business Overview
6.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nevro Implantable Neurostimulation Devices Product Portfolio
6.5.5 Nevro Recent Developments/Updates
6.6 NeuroPace
6.6.1 NeuroPace Corporation Information
6.6.2 NeuroPace Description and Business Overview
6.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NeuroPace Implantable Neurostimulation Devices Product Portfolio
6.6.5 NeuroPace Recent Developments/Updates
6.7 Beijing Pins
6.6.1 Beijing Pins Corporation Information
6.6.2 Beijing Pins Description and Business Overview
6.6.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Pins Implantable Neurostimulation Devices Product Portfolio
6.7.5 Beijing Pins Recent Developments/Updates
6.8 Synapse Biomedical
6.8.1 Synapse Biomedical Corporation Information
6.8.2 Synapse Biomedical Description and Business Overview
6.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Synapse Biomedical Implantable Neurostimulation Devices Product Portfolio
6.8.5 Synapse Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Neurostimulation Devices Industry Chain Analysis
7.2 Implantable Neurostimulation Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Neurostimulation Devices Production Mode & Process
7.4 Implantable Neurostimulation Devices Sales and Marketing
7.4.1 Implantable Neurostimulation Devices Sales Channels
7.4.2 Implantable Neurostimulation Devices Distributors
7.5 Implantable Neurostimulation Devices Customers
8 Implantable Neurostimulation Devices Market Dynamics
8.1 Implantable Neurostimulation Devices Industry Trends
8.2 Implantable Neurostimulation Devices Market Drivers
8.3 Implantable Neurostimulation Devices Market Challenges
8.4 Implantable Neurostimulation Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock